Vivanza Biosciences Ltd

BSE :530057 NSE :- Sector : Pharmac..
2.80
Change: 0.13(4.87%)
52 week Low
2.00
52 week High
9.54
Day low
2.80
Day high
2.80
Prev Close
2.67
Open
2.80
6M return
-30.86%
1Y return
-64.33%
MCap(Rs. in Cr.)
10.68
Total Volume
49,275
Face Value : 1
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
87.07%

Sales Industry Avg
26.35%

PAT
151.45%

PAT Industry Avg
4.42%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales26.8526.4130.1125.65101.58
Gross Profit17.3918.3125.0818.9477.13
Operating Profit00000
Profit Before Tax16.5617.3925.3417.7973.18
Tax3.294.455.463.5016.05
Profit After Tax13.2712.9419.8814.2957.13
Growth in 3 years

Total Asset Growth
NaN%

Total Liabilities growth
NaN%

Reserves Change
NaN%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
Mar 2024
( in Cr.)
Sales26.8526.4130.1125.65101.58
Gross Profit17.3918.3125.0818.9477.13
Operating Profit00000
Profit Before Tax16.5617.3925.3417.7973.18
Tax3.294.455.463.5016.05
Profit After Tax13.2712.9419.8814.2957.13
2023
2024 2025
2026


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Vivanza Biosci.
2.80
Change: 0.13 (4.87%)
1 Year return
-64.33%
Risk (Std Dev)
0.11%
PE Ratio
NM
MCap( in Cr.)
10.68
Shukra Pharma.
201.50
Change: -4.10 (-1.99%)
1 Year return
310.72%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Oxygenta Pharma
80.91
Change: -1.65 (-2.00%)
1 Year return
154.27%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Everest Organics
256.95
Change: 0.50 (0.20%)
1 Year return
88.66%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.90
Change: -0.04 (-0.06%)
1 Year return
19.75%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth with a of %

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

2023
2024
2025

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

News

Stay tuned to the latest developments and happenings in the company.

Vivanza Biosciences consolidated net profit declines 80.95% in the December 2024 quarter

Net profit of Vivanza Biosciences declined 80.95% to Rs 0.04 crore in the quarter ended December 2024 as against Rs 0.21 crore during the previous qua....

01 Feb 2025 07:43

Vivanza Biosciences to discuss results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live News....

25 Jan 2025 10:18

Vivanza Biosciences consolidated net profit declines 92.31% in the September 2024 quarter

Net profit of Vivanza Biosciences declined 92.31% to Rs 0.02 crore in the quarter ended September 2024 as against Rs 0.26 crore during the previous qu....

18 Oct 2024 07:32

Vivanza Biosciences to declare Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 17 October 2024.Powered by Capital Market - Live News....

11 Oct 2024 10:17

Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter

Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter....

09 Aug 2024 07:31

Vivanza Biosciences to announce Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live News</....

03 Aug 2024 17:02

View More
Subscribe for our
newsletter
Open Account Now